View drug registration information details.
| Items | Registration information |
|---|
| ID | 202 |
|---|
| No | 202 |
|---|
| Brand Name | BRATODX |
|---|
| Ingredients | ENCORAFENIB 75 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30 C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 42'S/BOTTLE |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH A BRAF V600E OR V600K MUTATION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | RED-WHITE CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 09 L 1201/24 |
|---|
| FDD Registration Date | 2024-09-24 |
|---|
| Expiry Date | 2029-09-23 |
|---|
Back to drug list
|
